Order Article Reprints

Hsu C-W, Yang W-W, Hou C-Y, Feng I-J, Huang T-Y, Lee P-L, Guo H-R, Huang C-Y, Su S-B. Patients with Hepatitis C Undergoing Direct-Acting Antiviral Treatment Have a Lower SARS-CoV-2 Infection Rate. Life. 2023; 13(12):2326. https://doi.org/10.3390/life13122326

Hsu, Chin-Wen, Wan-Wen Yang, Chia-Yi Hou, I-Jung Feng, Ting-Yi Huang, Pei-Lun Lee, How-Ran Guo, Chien-Yuan Huang, and Shih-Bin Su. 2023. "Patients with Hepatitis C Undergoing Direct-Acting Antiviral Treatment Have a Lower SARS-CoV-2 Infection Rate" Life 13, no. 12: 2326. https://doi.org/10.3390/life13122326

Hsu, C.-W., Yang, W.-W., Hou, C.-Y., Feng, I.-J., Huang, T.-Y., Lee, P.-L., Guo, H.-R., Huang, C.-Y., & Su, S.-B. (2023). Patients with Hepatitis C Undergoing Direct-Acting Antiviral Treatment Have a Lower SARS-CoV-2 Infection Rate. Life, 13(12), 2326. https://doi.org/10.3390/life13122326